Increased FoxP3 and PD-L1 in non-pCR tissue from early stage HER2 positive breast cancer patients treated with trastuzumab-pertuzumab based regimens.

Published

Conference Paper

Full Text

Published version (via Digital Object Identifier)

Duke Authors

Cited Authors

Force, JM; Howie, LJ; Abbott, S; Bentley, RC; Marcom, PK; Kimmick, GG; Westbrook, KE; Parks, M; Topping, DL; Broadwater, G; Blackwell, KL; Nair, SK

Published Date

May 20, 2016

Published In

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

Volume / Issue

34 / 15_suppl

Start / End Page

602 - 602

Published By

American Society of Clinical Oncology (ASCO)

Electronic International Standard Serial Number (EISSN)

1527-7755

International Standard Serial Number (ISSN)

0732-183X

Digital Object Identifier (DOI)

10.1200/jco.2016.34.15_suppl.602